May 24
Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device
Enhanced product to include significant operating enhancements and material design advances over the current offering
May 24
Enhanced product to include significant operating enhancements and material design advances over the current offering
May 03
Newly created position to spearhead technological innovation in the next stage of growth
Apr 06
Shareholders to benefit from greater transparency and improved liquidity on OTCQB
Mar 15
Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market
Jan 18
Commanding shareholder approval better positions management to attain enterprise business objectives going forward.
Jan 04
Agenda includes transformational matters affecting the Company’s position to manage impending growth
Dec 14
Updates to provide device improvements while maintaining the innovative core-functionality of CBSC’s state of the art cardiac event monitor.
Dec 07
Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.
Nov 30
Agenda to include matters necessary to better position the company for anticipated growth and development.
Nov 16
Upgraded listing would provide increased transparency and enhanced trading efficiency.